(Q44650640)

5 December 2017

The liver toxicity biomarker study phase I: markers for the effects of tolcapone or entacapone (English)

1 reference

5 December 2017

0 references

27

1 reference

5 December 2017

Robert N McBurney

1

1 reference

5 December 2017

Wade M Hines

2

1 reference

5 December 2017

Linda S VonTungeln

3

1 reference

5 December 2017

Laura K Schnackenberg

4

1 reference

5 December 2017

Richard D Beger

5

1 reference

5 December 2017

Carrie L Moland

6

1 reference

5 December 2017

Tao Han

7

1 reference

5 December 2017

James C Fuscoe

8

1 reference

5 December 2017

Ching-Wei Chang

9

1 reference

5 December 2017

James J Chen

10

1 reference

5 December 2017

Zhenqiang Su

11

1 reference

5 December 2017

Xiao-hui Fan

12

1 reference

5 December 2017

Weida Tong

13

1 reference

5 December 2017

Shelagh A Booth

14

1 reference

5 December 2017

Raji Balasubramanian

15

1 reference

5 December 2017

Paul L Courchesne

16

1 reference

5 December 2017

Jennifer M Campbell

17

1 reference

5 December 2017

Armin Graber

18

1 reference

5 December 2017

Yu Guo

19

1 reference

5 December 2017

Peter Juhasz

20

1 reference

5 December 2017

Tricia Y Li

21

1 reference

5 December 2017

Moira D Lynch

22

1 reference

5 December 2017

Nicole M Morel

23

1 reference

5 December 2017

Thomas N Plasterer

24

1 reference

5 December 2017

Edward J Takach

25

1 reference

5 December 2017

Chenhui Zeng

26

1 reference

5 December 2017

language of work or name

English

0 references

publication date

9 May 2012

1 reference

5 December 2017

Toxicologic Pathology

1 reference

5 December 2017

40

1 reference

5 December 2017

6

1 reference

5 December 2017

951-964

1 reference

A comparison of selected mRNA and protein abundances in human liver

5 December 2017

1 reference

https://api.crossref.org/works/10.1177%2F0192623312444026

Use of toxicogenomics to understand mechanisms of drug-induced hepatotoxicity during drug discovery and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623312444026

Identification and categorization of liver toxicity markers induced by a related pair of drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623312444026

Drug-induced liver injury: past, present and future.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623312444026

A retrospective analysis of toxicogenomics in the safety assessment of drug candidates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623312444026

Development of a large-scale chemogenomics database to improve drug candidate selection and to understand mechanisms of chemical toxicity and action

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623312444026

Correlation between protein and mRNA abundance in yeast

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623312444026

Toxicogenomics strategies for predicting drug toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623312444026

The liver toxicity biomarker study: phase I design and preliminary results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623312444026

Identification of metabolite profiles of the catechol-O-methyl transferase inhibitor tolcapone in rat urine using LC/MS-based metabonomics analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623312444026

21 January 2018

Identifiers

DOI

10.1177/0192623312444026

1 reference

5 December 2017

1 reference